Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Ericsson

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
Circulation|January 25, 2000
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery diseaseJ Björkegren, S Boquist, A Samnegârd, et al.
American Heart Journal|September 15, 1998
Emotional distress before coronary bypass grafting limits the benefits of surgeryA Perski, E Feleke, G Anderson, et al.
Acta Medica Scandinavica|January 1, 1988
Trends in coronary care. A retrospective study of patients with myocardial infarction treated in coronary care unitsC G Ericsson, B Lindvall, G Olsson, et al.
Clinical Physiology (Oxford, England)|July 1, 1992
Does diffuse coronary atherosclerosis affect the relation between coronary stenoses and uptake of thallium-201 after exercise?C G Ericsson, L Erhardt, A Hamsten, et al.
Journal of Internal Medicine|August 18, 2000
Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapyL E Strandberg, C G Ericsson, M L O'Konor, et al.
European Heart Journal|July 1, 1993
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptomsC G Ericsson, A Hamsten, C Landou, et al.
Journal of Internal Medicine|August 22, 2003
Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysisM Bennermo, C Held, A Hamsten, et al.
Journal of the American College of Cardiology|March 15, 2000
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatmentG Ruotolo, P Båvenholm, K Brismar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 17, 2008
Peritonectomy with high voltage electrocautery generates higher levels of ultrafine smoke particlesS N Andréasson, H Anundi, B Sahlberg, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
Circulation|January 25, 2000
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery diseaseJ Björkegren, S Boquist, A Samnegârd, et al.
American Heart Journal|September 15, 1998
Emotional distress before coronary bypass grafting limits the benefits of surgeryA Perski, E Feleke, G Anderson, et al.
Acta Medica Scandinavica|January 1, 1988
Trends in coronary care. A retrospective study of patients with myocardial infarction treated in coronary care unitsC G Ericsson, B Lindvall, G Olsson, et al.
Clinical Physiology (Oxford, England)|July 1, 1992
Does diffuse coronary atherosclerosis affect the relation between coronary stenoses and uptake of thallium-201 after exercise?C G Ericsson, L Erhardt, A Hamsten, et al.
Journal of Internal Medicine|August 18, 2000
Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapyL E Strandberg, C G Ericsson, M L O'Konor, et al.
European Heart Journal|July 1, 1993
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptomsC G Ericsson, A Hamsten, C Landou, et al.
Journal of Internal Medicine|August 22, 2003
Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysisM Bennermo, C Held, A Hamsten, et al.
Journal of the American College of Cardiology|March 15, 2000
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatmentG Ruotolo, P Båvenholm, K Brismar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 17, 2008
Peritonectomy with high voltage electrocautery generates higher levels of ultrafine smoke particlesS N Andréasson, H Anundi, B Sahlberg, et al.
Pageof 3